Cas:127253-44-5 (s)-(-)-8-methoxy 2-aminotetralin manufacturer & supplier

We serve Chemical Name:(s)-(-)-8-methoxy 2-aminotetralin CAS:127253-44-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(s)-(-)-8-methoxy 2-aminotetralin

Chemical Name:(s)-(-)-8-methoxy 2-aminotetralin
CAS.NO:127253-44-5
Synonyms:(s)-(-)-8-methoxy 2-aminotetralin
Molecular Formula:C11H15NO
Molecular Weight:177.24300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:309.1ºC at 760 mmHg
Density:1.056 g/cm3
Index of Refraction:1.548
PSA:35.25000
Exact Mass:177.11500
LogP:2.21150

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (s)-(-)-8-methoxy 2-aminotetralin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(s)-(-)-8-methoxy 2-aminotetralin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(s)-(-)-8-methoxy 2-aminotetralin Use and application,(s)-(-)-8-methoxy 2-aminotetralin technical grade,usp/ep/jp grade.


Related News: U.S. drugmaker Gilead dominates the HIV market and it will keep up the pressure with fast-growing Biktarvy, which was approved early last year. (s)-(-)-8-methoxy 2-aminotetralin manufacturer Retrogenix��s proprietary cell microarray technology provides a fast, accurate and effective solution for determining the primary target and secondary target (off-target) activities of antibodies, proteins, cell therapies, small molecules and viruses. (s)-(-)-8-methoxy 2-aminotetralin supplier FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus. (s)-(-)-8-methoxy 2-aminotetralin vendor The Branchburg factory first came under FDA scrutiny in late 2019, when agency inspectors began to document numerous quality control problems. By March, 2020, the FDA had deemed the manufacturing issues as “Official Action Indicated,” its most serious category of violation. (s)-(-)-8-methoxy 2-aminotetralin factory The Branchburg factory first came under FDA scrutiny in late 2019, when agency inspectors began to document numerous quality control problems. By March, 2020, the FDA had deemed the manufacturing issues as “Official Action Indicated,” its most serious category of violation.